Skip to main content
TipRanks
Go Ultimate75% OFF

enVVeno Medical (NVNO) Stock Statistics & Valuation Metrics

376 Followers

Total Valuation

enVVeno Medical has a market cap or net worth of $4.01M. The enterprise value is -$12.65M.

Market Cap
$4.01M
Enterprise Value
-$12.65M

Share Statistics

enVVeno Medical has 694,826 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
694,826
Owned by Insiders
9.09%
Owned by Institutions
10.28%

Financial Efficiency

enVVeno Medical’s return on equity (ROE) is -0.72 and return on invested capital (ROIC) is -75.10%.

Return on Equity (ROE)
-0.72
Return on Assets (ROA)
-0.66
Return on Invested Capital (ROIC)
-75.10%
Return on Capital Employed (ROCE)
-0.76
Revenue Per Employee
0
Profits Per Employee
-590.06K
Employee Count
33
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of enVVeno Medical is -0.02. enVVeno Medical’s PEG ratio is -0.00.

PE Ratio
-0.02
PS Ratio
0.00
PB Ratio
0.23
Price to FCF
-0.29
Price to Operating Cash Flow
-0.29
PEG Ratio
-0.00

Income Statement

In the last 12 months, enVVeno Medical had revenue of 0 and earned -19.47M in profits. Earnings per share was -33.06.

Revenue
0
Gross Profit
0
Operating Income
-20.90M
Pretax Income
-19.47M
Net Income
-19.47M
EBITDA
-18.98M
Earnings Per Share (EPS)
-33.06

Cash Flow

In the last 12 months, operating cash flow was -13.41M and capital expenditures 0, giving a free cash flow of -13.41M billion.

Operating Cash Flow
-13.41M
Free Cash Flow
-13.41M
Free Cash Flow per Share
-19.32

Dividends & Yields

enVVeno Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-363.41%
Earnings Yield
-422.02%

Stock Price Statistics

Beta
1.82
52-Week Price Change
-49.73%
50-Day Moving Average
7.88
200-Day Moving Average
10.05
Relative Strength Index (RSI)
28.81
Average Volume (3m)
30.09K

Important Dates

enVVeno Medical upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 30, 2026
Next Earnings Date
Mar 04, 2027
Ex-Dividend Date
―

Financial Position

enVVeno Medical as a current ratio of 13.58, with Debt / Equity ratio of 2.58%

Current Ratio
13.58
Quick Ratio
13.58
Debt to Market Cap
0.00
Net Debt to EBITDA
0.12
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, enVVeno Medical has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

enVVeno Medical EV to EBITDA ratio is -0.10, with an EV/FCF ratio of -0.11.

EV to Sales
0.00
EV to EBITDA
-0.10
EV to Free Cash Flow
-0.11
EV to Operating Cash Flow
-0.11

Balance Sheet

enVVeno Medical has $18.47M in cash and marketable securities with $408.00K in debt, giving a net cash position of $18.06M billion.

Cash & Marketable Securities
$18.47M
Total Debt
$408.00K
Net Cash
$18.06M
Net Cash Per Share
$26.00
Tangible Book Value Per Share
$24.35

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for enVVeno Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
―
EPS Growth Forecast
40.73%

Scores

Smart Score
―
AI Score
43